[HTML][HTML] The CXCL8-CXCR1/2 pathways in cancer
Persistent infection or chronic inflammation contributes significantly to tumourigenesis and
tumour progression. CXC motif ligand 8 (CXCL8) is a chemokine that acts as an important …
tumour progression. CXC motif ligand 8 (CXCL8) is a chemokine that acts as an important …
[HTML][HTML] Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
M Yi, D Jiao, S Qin, Q Chu, K Wu, A Li - Molecular cancer, 2019 - Springer
Immune checkpoint inhibitor (ICI) activates host’s anti-tumor immune response by blocking
negative regulatory immune signals. A series of clinical trials showed that ICI could effectively …
negative regulatory immune signals. A series of clinical trials showed that ICI could effectively …
[HTML][HTML] Chimeric antigen receptor T cells: a novel therapy for solid tumors
The chimeric antigen receptor T (CAR-T) cell therapy is a newly developed adoptive antitumor
treatment. Theoretically, CAR-T cells can specifically localize and eliminate tumor cells by …
treatment. Theoretically, CAR-T cells can specifically localize and eliminate tumor cells by …
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
…, C Le Sage, R Nagel, S Nair, DA Egan, A Li… - Nature cell …, 2008 - nature.com
MicroRNAs (miRNAs) are single-stranded, noncoding RNAs that are important in many
biological processes 1 , 2 . Although the oncogenic and tumour-suppressive functions of several …
biological processes 1 , 2 . Although the oncogenic and tumour-suppressive functions of several …
Evaluation of antioxidant and antibacterial activities of Ficus microcarpa L. fil. extract
Antioxidant and antibacterial activities were evaluated by the extracts of Ficus microcarpa,
which is one of the traditional medicinal plant and food additives in Okinawa, Japan. Results …
which is one of the traditional medicinal plant and food additives in Okinawa, Japan. Results …
[HTML][HTML] Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
S Qin, A Li, M Yi, S Yu, M Zhang, K Wu - Journal of hematology & oncology, 2019 - Springer
Angiogenesis has always been the topic of major scientific interest in the field of malignant
tumors. Nowadays, targeting angiogenesis has achieved success in various carcinomas by …
tumors. Nowadays, targeting angiogenesis has achieved success in various carcinomas by …
[HTML][HTML] Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
A Li, M Yi, S Qin, Y Song, Q Chu, K Wu - Journal of hematology & oncology, 2019 - Springer
During tumor progression, a subset of cancer cells escape from immune surveillance and
eventually develop into measurable tumor mass. Cancer immunotherapy eradicates tumor …
eventually develop into measurable tumor mass. Cancer immunotherapy eradicates tumor …
[HTML][HTML] The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the …
M Yi, A Li, L Zhou, Q Chu, Y Song, K Wu - Journal of hematology & …, 2020 - Springer
Background Acute myeloid leukemia (AML) is a common leukemia subtype and has a poor
prognosis. The risk of AML is highly related to age. In the context of population aging, a …
prognosis. The risk of AML is highly related to age. In the context of population aging, a …
[HTML][HTML] The role of cancer-derived microRNAs in cancer immune escape
M Yi, L Xu, Y Jiao, S Luo, A Li, K Wu - Journal of hematology & oncology, 2020 - Springer
During malignant transformation, accumulated somatic mutations endow cancer cells with
increased invasiveness and immunogenicity. Under selective pressure, these highly …
increased invasiveness and immunogenicity. Under selective pressure, these highly …
Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression
…, A Li, J Wang, W Xiao, K Chen, H Xiao, H Li… - Molecular cancer …, 2014 - AACR
PTENP1 is a pseudogene of the PTEN tumor suppression gene (TSG). The functions of
PTENP1 in clear-cell renal cell carcinoma (ccRCC) have not yet been studied. We found that …
PTENP1 in clear-cell renal cell carcinoma (ccRCC) have not yet been studied. We found that …